Paper89089
Antigenic specificity of neutralizing antibody to cholera toxin.
Peterson JW and 4 others. Infect Immun, 1979. Cited by 40 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Antigenic specificity of neutralizing antibody to cholera toxin. Papers, record 89089. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/89089
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antitoxins | Major topic |
| Cholera Toxin | Major topic |
| Animals | |
| Cholera | |
| Epitopes | |
| Hemagglutination Tests | |
| Humans | |
| Immunization | |
| Neutralization Tests | |
| Rabbits | |
| Radioimmunoassay |
Source PubMed
References7
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 71,268 | Radioimmunoassay for the antigenic determinants of cholera toxin and its components. | Infect Immun | 1977 | https://conductscience.org/library/papers/71268 | PubMed |
| 2 | 72,361 | Development of improved cholera vaccine based on subunit toxoid. | Nature | 1977 | https://conductscience.org/library/papers/72361 | PubMed |
| 3 | 88,548 | Structure, function, and antigenicity of cholera toxin. | J Supramol Struct | 1979 | https://conductscience.org/library/papers/88548 | PubMed |
| 4 | 903,363 | Covalent structure of the beta chain of cholera enterotoxin. | J Biol Chem | 1977 | https://conductscience.org/library/papers/903363 | PubMed |
| 5 | 4,205,946 | Development of a purified cholera toxoid. II. Preparation of a stable, antigenic toxoid by reaction of purified toxin with glutaraldehyde. | Infect Immun | 1974 | https://conductscience.org/library/papers/4205946 | PubMed |
| 6 | 5,883,637 | A permeability factor (toxin) found in cholera stools and culture filtrates and its neutralization by convalescent cholera sera. | Nature | 1965 | https://conductscience.org/library/papers/5883637 | PubMed |
| 7 | 16,557,689 | In vitro detection of antibody to cholera enterotoxin in cholera patients and laboratory animals. | Infect Immun | 1970 | https://conductscience.org/library/papers/16557689 | PubMed |
Cited by23
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 40 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39,934,422 | Protective antibodies against enterotoxigenic Escherichia coli are generated from heat-labile toxoid vaccination and exhibit subject- and vaccine-specific diversity. | Med Microbiol Immunol | 2025 | https://conductscience.org/library/papers/39934422 | PubMed |
| 31,776,240 | Vibrio cholerae at the Intersection of Immunity and the Microbiome. | mSphere | 2019 | https://conductscience.org/library/papers/31776240 | PubMed |
| 27,999,163 | Single-Cell Analysis of the Plasmablast Response to Vibrio cholerae Demonstrates Expansion of Cross-Reactive Memory B Cells. | mBio | 2016 | https://conductscience.org/library/papers/27999163 | PubMed |
| 26,305,793 | Evaluating the A-Subunit of the Heat-Labile Toxin (LT) As an Immunogen and a Protective Antigen Against Enterotoxigenic Escherichia coli (ETEC). | PLoS One | 2015 | https://conductscience.org/library/papers/26305793 | PubMed |
| 23,505,583 | Rapid and scalable plant-based production of a cholera toxin B subunit variant to aid in mass vaccination against cholera outbreaks. | PLoS Negl Trop Dis | 2013 | https://conductscience.org/library/papers/23505583 | PubMed |
| 22,140,551 | Engineered single-domain antibodies with high protease resistance and thermal stability. | PLoS One | 2011 | https://conductscience.org/library/papers/22140551 | PubMed |
| 10,457,227 | Mucosal immunogenicity and adjuvant activity of the recombinant A subunit of the Escherichia coli heat-labile enterotoxin. | Immunology | 1999 | https://conductscience.org/library/papers/10457227 | PubMed |
| 8,945,598 | Mutants of the Escherichia coli heat-labile enterotoxin with reduced ADP-ribosylation activity or no activity retain the immunogenic properties of the native holotoxin. | Infect Immun | 1996 | https://conductscience.org/library/papers/8945598 | PubMed |
| 7,964,489 | A genetically detoxified derivative of heat-labile Escherichia coli enterotoxin induces neutralizing antibodies against the A subunit. | J Exp Med | 1994 | https://conductscience.org/library/papers/7964489 | PubMed |
| 7,768,621 | Construction of nontoxic derivatives of cholera toxin and characterization of the immunological response against the A subunit. | Infect Immun | 1995 | https://conductscience.org/library/papers/7768621 | PubMed |
| 7,704,895 | Cholera. | Clin Microbiol Rev | 1995 | https://conductscience.org/library/papers/7704895 | PubMed |
| 7,400,099 | Lincomycin increases synthetic rate and periplasmic pool size for cholera toxin. | J Bacteriol | 1980 | https://conductscience.org/library/papers/7400099 | PubMed |
| 6,987,180 | Influence of route of administration on immediate and extended protection in rats immunized with Escherichia coli heart-labile enterotoxin. | Infect Immun | 1980 | https://conductscience.org/library/papers/6987180 | PubMed |
| 6,840,852 | Monoclonal antibodies to cholera toxin with special reference to cross-reactions with Escherichia coli heat-labile enterotoxin. | Infect Immun | 1983 | https://conductscience.org/library/papers/6840852 | PubMed |
| 6,389,350 | Construction of a potential live oral bivalent vaccine for typhoid fever and cholera-Escherichia coli-related diarrheas. | Infect Immun | 1984 | https://conductscience.org/library/papers/6389350 | PubMed |
| 6,365,779 | Characterization of monoclonal antibodies to heat-labile enterotoxin encoded by a plasmid from a clinical isolate of Escherichia coli. | Infect Immun | 1984 | https://conductscience.org/library/papers/6365779 | PubMed |
| 6,363,898 | New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development. | Microbiol Rev | 1983 | https://conductscience.org/library/papers/6363898 | PubMed |
| 6,335,849 | Local and systemic antibody responses and immunological memory in humans after immunization with cholera B subunit by different routes. | Bull World Health Organ | 1984 | https://conductscience.org/library/papers/6335849 | PubMed |
| 6,268,961 | Mechanism of action of choleragen and E. coli heat-labile enterotoxin: activation of adenylate cyclase by ADP-ribosylation. | Mol Cell Biochem | 1981 | https://conductscience.org/library/papers/6268961 | PubMed |
| 6,183,210 | Isolation of hybridoma cell lines and characterization of monoclonal antibodies against cholera enterotoxin and its subunits. | Infect Immun | 1982 | https://conductscience.org/library/papers/6183210 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/89089
GET https://conductscience.org/api/papers/v1/89089/cited_by?page=2